Therapy for spinal muscular atrophy

Research output: Chapter in Book/Report/Conference proceedingChapter


Spinal muscular atrophy is a term applied to both a specific and common disorder, and to a group of related but individually rare disorders. The specific, common disorder is also known as childhood spinal muscular atrophy, proximal spinal muscular atrophy, and historically has been broken up into several subgroups labeled SMA 1 (Werdnig Hoffmann disease), SMA 2 (intermediate childhood SMA), and SMA 3 (Kugelberg Welander disease). All of these labels refer to a recessively inherited genetic disorder caused by mutation of the survival motor neuron gene, SMN. The group of disorders collectively known as the spinal muscular atrophies (Table 1) is diverse in many respects. Some are well characterized genetically by defined mutations in known genes, some are clearly genetic from their inheritance pattern but as yet involve unknown genes, and others affect single patients in a manner that suggests a genetic etiology that yet remains unproven. Both the specific SMN-related SMA and the broad range of SMA disorders share in common certain clinical features including slow progressive, symmetric and often diffuse weakness caused by degeneration of the primary motor neurons. Symmetric dysfunction and degeneration of spinal and bulbar motor neurons may be a feature of other disorders (Table 2).

Original languageEnglish (US)
Title of host publicationTreatment of Pediatric Neurologic Disorders
PublisherCRC Press
Number of pages10
ISBN (Electronic)9780849340888
ISBN (Print)0824726936, 9780824726935
StatePublished - Jan 1 2005

ASJC Scopus subject areas

  • General Medicine


Dive into the research topics of 'Therapy for spinal muscular atrophy'. Together they form a unique fingerprint.

Cite this